EX-23.1 9 itrm-ex231_6.htm EX-23.1 itrm-ex231_6.htm

EXHIBIT 23.1

 

 

 

 

Consent of Independent Registered Public Accounting Firm

 

 

 

 

We consent to the use of our report dated March 28, 2022, with respect to the consolidated financial statements of Iterum Therapeutics plc, incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.

 

 

 

/s/ KPMG

 

KPMG

 

Dublin, Ireland

October 7, 2022